iBio (IBIO) Net Margin Growth (1y) (2012 - 2025)
iBio (IBIO) Net Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 447.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 2,072.00 |
| 10 | iBio | 167.44 Mn | 167.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,371.00 |
| Mar 31, 2022 | 32,147.00 |
| Sep 30, 2021 | -440,135.00 |
| Jun 30, 2021 | 33,208.00 |
| Mar 31, 2021 | 392,874.00 |
| Dec 31, 2020 | 692,276.00 |
| Sep 30, 2020 | 234,010.00 |
| Jun 30, 2020 | 25,289.00 |
| Mar 31, 2020 | -412,507.00 |
| Dec 31, 2019 | -738,856.00 |
| Sep 30, 2019 | 572,648.00 |
| Jun 30, 2019 | 435,178.00 |
| Mar 31, 2019 | 434,807.00 |
| Dec 31, 2018 | 189,438.00 |
| Sep 30, 2018 | -672,984.00 |
| Jun 30, 2018 | -193,794.00 |
| Mar 31, 2018 | 548,441.00 |
| Dec 31, 2017 | 171,448.00 |
| Sep 30, 2017 | -92,276.00 |
| Jun 30, 2017 | -201,498.00 |